Skip to content

Canadian Observational Study Evaluating the Long-term IMPACT of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators on People With CF

Cystic Fibrosis

This observational study intends to investigate health trends and data in cystic fibrosis patients all across Canada that are receiving modulator treatment so researchers can determine if CFTR treatments are effective over a long period of time and if so, which treatments work best for each individual. The study will collect clinical data from routine standard of care, patient reported outcomes via survey data and samples for a biobank.

null

Participation Requirements

  • Sex:

    ALL

  • Eligible Ages:

    0 and up

Participation Criteria

Inclusion Criteria:

* Prescribed a CFTR modulator therapy and planning to commence modulator therapy within 30 days OR planning to switch modulator therapies within 30 days
* Participates in the Canadian Cystic Fibrosis Registry (CCFR)
* Informed consent by participant, or parent/legal guardian or assent

Exclusion Criteria:

* Known contraindications to CFTR modulator therapy

Study Location

British Columbia Children's Hospital
British Columbia Children's Hospital
Vancouver, British Columbia
Canada

Contact Study Team

Primary Contact

Britney Ha

[email protected]
604-875-2345
Backup Contact

Vanessa Diamond

[email protected]
604-875-2345
St Paul's Hospital
St Paul's Hospital
Vancouver, British Columbia
Canada

Contact Study Team

Backup Contact

Taryn Leach

[email protected]
Primary Contact

Ronak Salamat

[email protected]
604-806-9158
Study Sponsored By
University of British Columbia
Participants Required
More Information
Study ID: NCT05200429